Meet Our Team

Steven Bogen MD PhD (President)
Dr. Bogen is a Board-certified Clinical Pathologist, having graduated from the University of Chicago Pritzker School of Medicine (M.D.) and the Weizman Institute of Science (Ph.D.), with a post-graduate residency and research fellowship at the Brigham and Women’s Hospital.
He is Adjunct Professor of Pathology and Laboratory Medicine at Boston University School of Medicine and Medical Director, Clinical Chemistry Laboratory (part-time) at Tufts Medical Center. Dr. Bogen is an inventor on 22 patents, all of which relate to various medical diagnostic technologies.
In addition, he served for a decade on several NIH grant review committees, mainly for the Innovative Molecular Analysis of Cancer Technologies program sponsored by the National Cancer Institute. Dr. Bogen was previously the founder of CytoLogix Corporation, which developed the Artisan® instrument system for automated complex histopathology stains (now sold and supported by Dako Corporation).

Seshi Sompuram PhD (Vice President, Research & Development)
Dr. Sompuram is Co-founder and VP R&D of Medical Discovery Partners LLC. He is also an Adjunct Assistant Professor of Pathology and Laboratory Medicine at Boston University School of Medicine. He received his PhD and trained as a Post-Doctoral Fellow at Boston University School of Medicine (Pathology/Immunology).
Previously, he was Research Manager at Cytologix Corp., Cambridge MA. Dr. Sompuram is an inventor on 5 patents and co-authored numerous publications and textbooks. He has almost three decades of expertise in molecular biology, antibody engineering, and phage-display technologies (both antibody and peptide phage display). Dr. Sompuram has led the team’s efforts in applying these technologies in the area of cancer detection and diagnosis.

Kodela Vani MS (Manager, Manufacturing & Production)
Ms. Vani has over 20 years of laboratory experience in biochemistry and molecular biology and has operational responsibility for MDP’s cGMP manufacturing processes. After receiving a Masters degree in Chemistry, she initially worked in Drosophila genetics at Columbia University, NY and later in R&D at CytoLogix Corp., Cambridge MA.
She has a broad range of research laboratory expertise, covering molecular biology, immunology, and pathology, and is a co-author on numerous peer-reviewed journal articles.

Anuradha Balasubramanian PhD (Quality Systems)
Dr. Balasubramanian has over 17 years of experience in preclinical toxicology, regenerative therapeutics, and developmental biology. Serving as a Quality and Compliance consultant, she oversees the in vitro medical device product development, QSR documentation, and compliance of the MDP product lines with cGMP regulations.
Most recently, she is a consultant involved in CMC regulatory operations for drugs and biologics. Previously as a Scientist/Pediatric fellow in Boston Children’s Hospital/Harvard Medical School, she has held positions of increasing responsibility in research and laboratory management. She had also served as a post-doctoral fellow in Beth Israel Deaconess Medical Center/Harvard Medical School.
Anuradha received her M.S. and Ph.D in Biochemistry from the University of Madras in India.